EODData

LSE, 0WA2: Cellectis S.A.

13 Nov 2025
LAST:

3.205

CHANGE:
 0.10
OPEN:
3.205
HIGH:
3.205
ASK:
1.828
VOLUME:
50
CHG(%):
3.03
PREV:
3.235
LOW:
1.386
BID:
1.740
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
13 Nov 253.2053.2051.3863.20550
12 Nov 253.2753.5253.2753.3336.1K
11 Nov 253.1903.2353.1503.2357.1K
10 Nov 253.0503.2803.0203.1805.8K
07 Nov 252.8702.8852.8302.830107
06 Nov 252.9402.9602.8702.870229
05 Nov 252.9002.9702.9002.933702
04 Nov 252.8702.9432.8702.943384
03 Nov 253.0553.0702.9102.910219
31 Oct 253.0053.1003.0053.090203

COMPANY PROFILE

Name:Cellectis S.A.
About:Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications. The company is developing ALLO-501 to treat large B-cell lymphoma; ALLO-316, a gene-edited allogeneic CAR T-cell product targeting CD70; ALLO-819 to treat acute myeloid leukemia; ALLO-213 for the treatment of small cell lung cancer; and ALLO-182 to treat gastric and pancreatic cancer. It also develops UCART22 for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia; UCART123 to treat acute myeloid leukemia; UCART 20x22 for relapsed or refractory B-Cell non-hodgkin's lymphoma; and cema-cel to treat relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma. The company was founded in 1999 and is headquartered in Paris, France.
Address:8, rue de la Croix Jarry, Paris, France, 75013
Website:https://www.cellectis.com

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-7.18 
Price to Sales:8.52 
Price to Book:1.68 
Profit Margin:0.78 
Operating Margin:-3.20 
Return on Assets:-0.18 
Return on Equity:-0.63 
Revenue:21.49M 

TECHNICAL INDICATORS

MA5:3.093.7%
MA10:3.045.5%
MA20:3.132.2%
MA50:3.035.8%
MA100:2.5326.8%
MA200:1.9464.9%
STO9:72.37
STO14:72.37
RSI14:63.48 
MTM14:0.34
ROC14:0.11 
ATR:0.18 
Week High:3.5310.0%
Week Low:2.8313.3%
Month High:4.8451.0%
Month Low:2.8364.9%
Year High:4.8451.0%
Year Low:1.01217.5%
Volatility:12.54